ClearPoint Neuro (CLPT) Other financing activities (2016 - 2026)

ClearPoint Neuro has disclosed Other financing activities across 7 years of filings, most recently posting $2.2 million for Q1 2026.

• Other financing activities for Q1 2026 came in at $2.2 million, up 69.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 58.72% YoY), and the FY2025 annual result was $1.9 million, down 73.13% from the prior year.
• Other financing activities came in at $2.2 million for Q1 2026 at ClearPoint Neuro, up from -$3.7 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $3.5 million in Q4 2024 to a low of -$3.7 million in Q4 2025.
• The 3-year median for Other financing activities is $1.8 million (2024), against an average of $1.2 million.
• Peak annual rise in Other financing activities reached 3214.75% in 2025, while the deepest fall reached 205.47% in 2025.
• ClearPoint Neuro's Other financing activities stood at $3.5 million in 2024, then tumbled by 205.47% to -$3.7 million in 2025, then surged by 159.3% to $2.2 million in 2026.
• The last three Other financing activities figures came in at $2.2 million (Q1 2026), -$3.7 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.